Bacampicillin

Bacampicillin (INN) is a penicillin antibiotic. It serves as a prodrug designed to improve the oral bioavailability of ampicillin.
History and Development[edit]
Bacampicillin was developed to enhance the absorption of ampicillin in the body. As a prodrug, bacampicillin is metabolized in the body to produce ampicillin, thereby allowing for greater concentrations of the antibiotic in the bloodstream when taken orally.
Brand Names and Availability[edit]
Bacampicillin is marketed under the following brand names:
- Spectrobid – Manufactured by Pfizer
- Penglobe – Produced by AstraZeneca
Despite its usage in various regions, bacampicillin is not available in the United States.
Mechanism of Action[edit]
Like ampicillin, bacampicillin functions by inhibiting the synthesis of the bacterial cell wall, leading to the death of susceptible bacteria. The primary advantage of bacampicillin over ampicillin is its improved bioavailability when taken orally, ensuring more consistent therapeutic levels in the body.
Indications[edit]
Bacampicillin is prescribed for the treatment of various bacterial infections, especially those caused by penicillin-sensitive organisms. Its efficacy and indications largely align with those of ampicillin due to its conversion to ampicillin in vivo.
Side Effects and Precautions[edit]
Patients using bacampicillin may experience side effects common to penicillin antibiotics, such as gastrointestinal disturbances, allergic reactions, and skin rashes. It is essential to avoid use in patients with known penicillin allergies.
References[edit]
- Johnson, L.R. (2015). Antibiotics and Their Applications. Oxford University Press.
- Smith, A. & Green, B. (2013). Modern Developments in Antibacterial Therapy. Elsevier.
Penicillin antibiotics[edit]
- penicillins first generation (natural penicillins)
- penicillins second generation (penicillinase-resistant penicillins)
- penicillins third generation (aminopenicillins)
- see also amoxicillin-clavulanate
- penicillins fourth generation (extended-spectrum penicillins)
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian